U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Development Resources
  5. Cefuroxime - Injection products
  1. Development Resources

Cefuroxime - Injection products

Exceptions or additions to the recognized standards

 

Minimum Inhibitory
Concentrations
(mcg/mL)

Disk Diffusion
(zone diameter in mm)

Pathogen

S

I

R

S

I

R

Enterobacterales

≤8

 -

≥16

≥18

 -

≤17

S = Susceptible; I = Intermediate; R = Resistant

For Enterobacterales, susceptibility interpretive criteria are based on a dose of 1.5g every 8 hours in patients with normal renal function

Back to Top